Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Conditions

Myelodysplastic Syndromes 2Leukemia 2Infections 2Wilms Tumor 1Sarcoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neutropenia 1Neuroblastoma 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Biphenotypic, Acute 1Kidney Neoplasms 1Intraocular Lymphoma 1Immunoblastic Lymphadenopathy 1Hematologic Neoplasms 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1Bronchiolitis Obliterans Syndrome 1Blast Crisis 1

Interventions

Voriconazole 2Caspofungin 2telavancin 1monalizumab 1fludarabine phosphate 1fish oil triglycerides 1avdoralimab 1Whole-Body Irradiation 1Trimethoprim, Sulfamethoxazole Drug Combination 1Therapeutics 1Tacrolimus 1Standard of Care 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Observation 1Methotrexate 1Melphalan 1Interferon-gamma 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Daptomycin 1Cyclophosphamide 1Clarithromycin 1Bevacizumab 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Infections × Voriconazole × Clear all
NCT00238355 2025-04-27

Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune Systems

OHSU Knight Cancer Institute

Phase 2 Terminated
13 enrolled 8 charts

Infections

NCT00059878 2013-06-19

Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal Infections

National Cancer Institute (NCI)

Phase 2 Completed

Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡